Patient Portal

We are so glad you’re here! We want this page to be your home on the web where you can come to learn about the latest news affecting lung cancer patients, get support from stories shared by other patients, and maybe tell your own.

We also want you to know that we are here for you! If you have questions about information we have here, navigating the complex path of cancer treatment, or anything else, please don’t hesitate to get in touch with us. Your message will be delivered directly to Danielle Hicks (Director of Patient Services and Programs), Michele Zeh (Patient Navigation and Services Coordinator), and Guneet Walia, PhD (Director of Research and Medical Affairs). They are always happy to hear from you.

Also, if you are ROS1-positive, we have a special portal area dedicated to ROS1ers. Please click this link to go there.

Regardless of where you are on your cancer journey, ALCF is with you.

Latest News for Patients

Read Bonnie’s blog post about the excitement in Lung Research from ASCO

June 20th, 2017

This year at ASCO, lung cancer was all the buzz. Lung cancer is quickly becoming the lead in the discovery of cancer mutations and other drivers relative to advancing therapies and survival. There are now many possibilities in the future of all cancers beginning with chronic management and onto future cures. Read Bonnie’s blog about… Read More

ALCF Announces Winners of a Crowdsourcing Challenge to Increase Patient Enrollment in Oncology Clinical Trials

May 15th, 2017

Two winners will be awarded a total of $180,000 for the Bonnie J. Addario Lung Cancer Foundation (ALCF) Clinical Trial Innovation Prize, an international crowdsourcing challenge seeking innovative ways to increase cancer patient enrollment in clinical trials. First prize was awarded to Samir Housri and Nadine Housri who developed theMednet, a social network for physicians,… Read More

ALCMI and Biocept Announce a Landmark Liquid Biopsy Clinical Trial

May 10th, 2017

The Addario Lung Cancer Medical Institute (ALCMI) and Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announce a clinical collaboration and initiation of the landmark ALCMI-009 liquid biopsy clinical trial, which was developed and will be conducted by ALCMI and its consortium of… Read More